About Index Trending news
Lists
Pricing
Cerulean Pharma, Inc

Cerulean Pharma, Inc

Cerulean Pharma, Inc

Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.

Elsewhere

Alexa global traffic share

07 Apr 2015
$35,000,000
Post-IPO equity
09 Jan 2015
$26,000,000
Debt financing
15 Dec 2011
$15,000,000
Venture capital (Series D)
15 Nov 2010
$24,000,000
Venture capital (Series C)
03 Jan 2008
$8,100,000
Venture capital (Series B)
23 May 2007
$12,100,000
Venture capital (Series A)
01 Dec 2006
$2,000,000
Venture capital